Clinical Trial Update: A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing SMT19969 with vancomycin for Clostridioides difficile infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• SMT19969 (SMT19969)
• Vancomycin (vancomycin)

Snippet

Sponsor: Summit Therapeutics | Conditions: Clostridium Difficile Infection | Phase 2 | Status: COMPLETED